BamSEC and AlphaSense Join Forces
Learn More

Solventum Corporation

NYSE: SOLV    
Share price (9/19/25): $73.72    
Market cap (9/19/25): $12.8 billion

Material Contracts Filter

EX-10.15
from 10-Q 22 pages Material contract
12/34/56
EX-10.24
from 10-K 6 pages Material contract
12/34/56
EX-10.23
from 10-K 6 pages Material contract
12/34/56
EX-10.22
from 10-K 6 pages Material contract
12/34/56
EX-10.21
from 10-K 6 pages Material contract
12/34/56
EX-10.20
from 10-K 6 pages Material contract
12/34/56
EX-10.19
from 10-K 15 pages Material contract
12/34/56
EX-10.1
from 8-K 16 pages Material contract
12/34/56
EX-10.3
from 8-K 17 pages Solventum 2024 Long-Term Incentive Plan Performance Share Unit Agreement
12/34/56
EX-10.2
from 8-K 7 pages Solventum 2024 Long-Term Incentive Plan Restricted Stock Unit Award Agreement for Non-Employee Directors
12/34/56
EX-10.1
from 8-K 29 pages Solventum 2024 Long-Term Incentive Plan Restricted Stock Unit Award Agreement
12/34/56
EX-10.14
from 8-K 18 pages Solventum Executive Severance Plan Summary Plan Description Effective Date: April 1, 2024
12/34/56
EX-10.13
from 8-K 6 pages Solventum Annual Incentive Plan
12/34/56
EX-10.11
from 8-K 33 pages Reverse Master Supply Agreement by and Between Solventum Corporation and 3m Company Dated as of March 31, 2024
12/34/56
EX-10.10
from 8-K 34 pages Master Supply Agreement by and Between 3m Company and Solventum Corporation Dated as of March 31, 2024
12/34/56
EX-10.9
from 8-K 22 pages Transitional Trademark Cross License Agreement by and Among 3m Company, 3m Innovative Properties Company and Solventum Corporation, Solventum Intellectual Properties Company, 3m Healthcare Germany Gmbh Dated as of March 31, 2024
12/34/56
EX-10.8
from 8-K 20 pages 3m Trademark Use Agreement by and Among 3m Company, 3m Innovative Properties Company, Solventum Corporation and Solventum Intellectual Properties Company Dated as of March 31, 2024
12/34/56
EX-10.7
from 8-K 28 pages Intellectual Property Cross License Agreement by and Among 3m Company 3m Innovative Properties Company 3m Healthcare US Opco LLC and Solventum Intellectual Properties Company Dated as of March 31, 2024
12/34/56
EX-10.6
from 8-K 26 pages Stockholder and Registration Rights Agreement
12/34/56
EX-10.5
from 8-K 31 pages Transition Contract Manufacturing Agreement by and Between 3m Company and Solventum Corporation Dated as of March 31, 2024
12/34/56